H1受容体
WordNet
- the 8th letter of the Roman alphabet (同)h
- amine formed from histidine that stimulates gastric secretions and dilates blood vessels; released by the human immune system during allergic reactions
- a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response
PrepTutorEJDIC
- hydrogenの化学記号
- 鉛筆の硬度 / 《俗》heroin
- ヒスタミン(子宮収縮・血圧降下の薬)
- =sense organ / 受信装置
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/05/23 12:58:18」(JST)
[Wiki en表示]
Histamine receptor H1 |
Histamine H1 receptor in complex with doxepin(PDB entry 3RZE) |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
3RZE
|
|
|
Identifiers |
Symbols |
HRH1 ; H1-R; hisH1 |
External IDs |
OMIM: 600167 MGI: 107619 HomoloGene: 668 IUPHAR: 262 ChEMBL: 231 GeneCards: HRH1 Gene |
Gene ontology |
Molecular function |
• G-protein coupled receptor activity
• histamine receptor activity
|
Cellular component |
• plasma membrane
• integral component of plasma membrane
|
Biological process |
• inflammatory response
• G-protein coupled receptor signaling pathway
• phospholipase C-activating G-protein coupled receptor signaling pathway
• memory
• visual learning
• positive regulation of inositol trisphosphate biosynthetic process
• regulation of vascular permeability
• positive regulation of vasoconstriction
• inositol phosphate-mediated signaling
• regulation of synaptic plasticity
• eosinophil chemotaxis
• cellular response to histamine
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
3269 |
15465 |
|
Ensembl |
ENSG00000196639 |
ENSMUSG00000053004 |
|
UniProt |
P35367 |
P70174 |
|
RefSeq (mRNA) |
NM_000861 |
NM_001252642 |
|
RefSeq (protein) |
NP_000852 |
NP_001239571 |
|
Location (UCSC) |
Chr 3:
11.18 – 11.31 Mb |
Chr 6:
114.4 – 114.48 Mb |
|
PubMed search |
[1] |
[2] |
|
|
The H1 receptor is a histamine receptor belonging to the family of Rhodopsin-like G-protein-coupled receptors. This receptor, which is activated by the biogenic amine histamine, is expressed throughout the body, to be specific, in smooth muscles, on vascular endothelial cells, in the heart, and in the central nervous system. The H1 receptor is linked to an intracellular G-protein (Gq) that activates phospholipase C and the phosphatidylinositol (PIP2) signaling pathway. Antihistamines, which act on this receptor, are used as anti-allergy drugs. The crystal structure of the receptor has been determined (shown on the right)[1] and used to discover new histamine H1 receptor ligands in structure-based virtual screening studies.[2]
Contents
- 1 Role in inflammation
- 2 Neurophysiology
- 3 See also
- 4 References
- 5 Further reading
- 6 External links
Role in inflammation
The production of prostaglandin E2 synthase induces the release of histamine from neurons, causing systemic vasodilation, along with increased cell permeability due to its action on H1 receptors.[citation needed]
Neurophysiology
Histamine H1 receptors are activated by endogenous histamine, which is released by neurons that have their cell bodies in the tuberomammillary nucleus of the hypothalamus. The histaminergic neurons of the tuberomammillary nucleus become active during the 'wake' cycle, firing at approximately 2 Hz; during slow wave sleep, this firing rate drops to approximately 0.5 Hz. Finally, during REM sleep, histaminergic neurons stop firing altogether. It has been reported that histaminergic neurons have the most wake-selective firing pattern of all known neuronal types.[3]
In the cortex, activation of H1 receptors leads to inhibition of cell membrane potassium channels. This depolarizes the neurons and increases the resistance of the neuronal cell membrane, bringing the cell closer to its firing threshold and increasing the excitatory voltage produced by a given excitatory current. H1 receptor antagonists, or antihistamines, produce drowsiness because they oppose this action, reducing neuronal excitation.[4]
See also
- Antihistamine – H1-receptor antagonists
References
- ^ Tatsuro Shimamura, Mitsunori Shiroishi, Simone Weyand, Hirokazu Tsujimoto, Graeme Winter, Vsevolod Katritch, Ruben Abagyan, Vadim Cherezov, Wei Liu, Gye Won Han, Takuya Kobayashi, Raymond C. Stevens & So Iwata (July 2011). "Structure of the human histamine H1 receptor complex with doxepin". Nature 475 (7354): 65–70. doi:10.1038/nature10236. PMC 3131495. PMID 21697825.
- ^ de Graaf C, Kooistra AJ, Vischer HF, Katritch V, Kuijer M, Shiroishi M, Iwata S, Shimamura T, Stevens RC, de Esch IJ, Leurs R (2011). "Crystal structure-based virtual screening for fragment-like ligands of the human histamine H1 receptor". J Med Chem 54 (23): 8195–8206. doi:10.1021/jm2011589. PMC 3228891. PMID 22007643.
- ^ Passani MB, Lin JS, Hancock A, Crochet S, Blandina P (December 2004). "The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders". Trends Pharmacol. Sci. 25 (12): 618–25. doi:10.1016/j.tips.2004.10.003. PMID 15530639.
- ^ Reiner PB, Kamondi A (April 1994). "Mechanisms of antihistamine-induced sedation in the human brain: H1 receptor activation reduces a background leakage potassium current". Neuroscience 59 (3): 579–88. doi:10.1016/0306-4522(94)90178-3. PMID 8008209.
Further reading
- Mitsuchashi M, Payan DG (1989). "Molecular and cellular analysis of histamine H1 receptors on cultured smooth muscle cells.". J. Cell. Biochem. 40 (2): 183–92. doi:10.1002/jcb.240400207. PMID 2670975.
- Braman SS (1987). "Histamine receptors in the lung.". N Engl Reg Allergy Proc 8 (2): 116–20. doi:10.2500/108854187778994446. PMID 2886904.
- Hill SJ, Ganellin CR, Timmerman H et al. (1997). "International Union of Pharmacology. XIII. Classification of histamine receptors.". Pharmacol. Rev. 49 (3): 253–78. PMID 9311023.
- Holden CA, Chan SC, Norris S, Hanifin JM (1988). "Histamine induced elevation of cyclic AMP phosphodiesterase activity in human monocytes.". Agents Actions 22 (1–2): 36–42. doi:10.1007/BF01968814. PMID 2891264.
- Moguilevsky N, Varsalona F, Noyer M et al. (1994). "Stable expression of human H1-histamine-receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the gene". Eur. J. Biochem. 224 (2): 489–95. doi:10.1111/j.1432-1033.1994.00489.x. PMID 7925364.
- Fukui H, Fujimoto K, Mizuguchi H et al. (1994). "Molecular cloning of the human histamine H1 receptor gene". Biochem. Biophys. Res. Commun. 201 (2): 894–901. doi:10.1006/bbrc.1994.1786. PMID 8003029.
- Le Coniat M, Traiffort E, Ruat M et al. (1994). "Chromosomal localization of the human histamine H1-receptor gene". Hum. Genet. 94 (2): 186–8. doi:10.1007/bf00202867. PMID 8045566.
- De Backer MD, Gommeren W, Moereels H et al. (1994). "Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor". Biochem. Biophys. Res. Commun. 197 (3): 1601–8. doi:10.1006/bbrc.1993.2662. PMID 8280179.
- Hishinuma S, Young JM (1996). "Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation". Br. J. Pharmacol. 116 (6): 2715–23. doi:10.1111/j.1476-5381.1995.tb17232.x. PMC 1909113. PMID 8590995.
- Max SI, Chowdhury BA, Fraser CM (1996). "Sequence analysis of the 5'-untranslated region of the human H1 histamine receptor-encoding gene". Gene 171 (2): 309–10. doi:10.1016/0378-1119(96)00036-4. PMID 8666296.
- De Backer MD, Loonen I, Verhasselt P et al. (1998). "Structure of the human histamine H1 receptor gene". Biochem. J. 335 (3): 663–70. PMC 1219830. PMID 9794809.
- Horváth BV, Szalai C, Mándi Y et al. (1999). "Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon gamma in peripheral human blood mononuclear cells and in CD19-depleted cell subsets". Immunol. Lett. 70 (2): 95–9. doi:10.1016/S0165-2478(99)00126-1. PMID 10569698.
- Wang KY, Arima N, Higuchi S et al. (2000). "Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages". FEBS Lett. 473 (3): 345–8. doi:10.1016/S0014-5793(00)01560-X. PMID 10818238.
- Oda T, Morikawa N, Saito Y et al. (2001). "Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes". J. Biol. Chem. 275 (47): 36781–6. doi:10.1074/jbc.M006480200. PMID 10973974.
- Brew OB, Sullivan MH (2002). "Localisation of mRNAs for diamine oxidase and histamine receptors H1 and H2, at the feto-maternal interface of human pregnancy". Inflamm. Res. 50 (9): 449–52. doi:10.1007/PL00000269. PMID 11603849.
- Gutzmer R, Langer K, Lisewski M et al. (2002). "Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells". J. Allergy Clin. Immunol. 109 (3): 524–31. doi:10.1067/mai.2002.121944. PMID 11898002.
- Idzko M, la Sala A, Ferrari D et al. (2002). "Expression and function of histamine receptors in human monocyte-derived dendritic cells". J. Allergy Clin. Immunol. 109 (5): 839–46. doi:10.1067/mai.2002.124044. PMID 11994709.
External links
- "Histamine Receptors: H1". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.
Histaminergics
|
|
Receptor
(ligands) |
H1 |
- Agonists: 2-Pyridylethylamine
- Betahistine
- Histamine
- HTMT
- UR-AK49
- Antagonists: First-generation: 4-Methyldiphenhydramine
- Alimemazine
- Antazoline
- Azatadine
- Bamipine
- Benzatropine (benztropine)
- Bepotastine
- Bromazine
- Brompheniramine
- Buclizine
- Captodiame
- Carbinoxamine
- Chlorcyclizine
- Chloropyramine
- Chlorothen
- Chlorphenamine
- Chlorphenoxamine
- Cinnarizine
- Clemastine
- Clobenzepam
- Clocinizine
- Cyclizine
- Cyproheptadine
- Dacemazine
- Decloxizine
- Deptropine
- Dexbrompheniramine
- Dexchlorpheniramine
- Dimenhydrinate
- Dimetindene
- Diphenhydramine
- Diphenylpyraline
- Doxylamine
- Embramine
- Etodroxizine
- Etybenzatropine (ethylbenztropine)
- Etymemazine
- Flunarizine
- Histapyrrodine
- Homochlorcyclizine
- Hydroxyethylpromethazine
- Hydroxyzine
- Isopromethazine
- Isothipendyl
- Meclozine
- Medrylamine
- Mepyramine (pyrilamine)
- Mequitazine
- Methafurylene
- Methapyrilene
- Methdilazine
- Moxastine
- Orphenadrine
- Oxatomide
- Oxomemazine
- Phenindamine
- Pheniramine
- Phenyltoloxamine
- Pimethixene
- Piperoxan
- Pipoxizine
- Promethazine
- Propiomazine
- Pyrrobutamine
- Talastine
- Thenalidine
- Thenyldiamine
- Thiazinamium
- Thonzylamine
- Tolpropamine
- Tripelennamine
- Triprolidine
- Second/third-generation: Acrivastine
- Alinastine
- Astemizole
- Azelastine
- Bamirastine
- Barmastine
- Bepiastine
- Bepotastine
- Bilastine
- Cabastinen
- Carebastine
- Cetirizine
- Clemastine
- Clemizole
- Clobenztropine
- Desloratadine
- Dorastine
- Ebastine
- Efletirizine
- Emedastine
- Epinastine
- Fexofenadine
- Flezelastine
- Ketotifen
- Latrepirdine
- Levocabastine
- Levocetirizine
- Linetastine
- Loratadine
- Mapinastine
- Mebhydrolin
- Mizolastine
- Moxastine
- Noberastine
- Octastine
- Olopatadine
- Perastine
- Pibaxizine
- Piclopastine
- Rocastine
- Rupatadine
- Setastine
- Talastine
- Temelastine
- Terfenadine
- Vapitadine
- Zepastine
- Non-generational: Atypical antipsychotics (e.g., aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone, zotepine)
- Tetracyclic antidepressants (e.g., amoxapine, loxapine, maprotiline, mianserin, mirtazapine, oxaprotiline)
- Tricyclic antidepressants (e.g., amitriptyline, butriptyline, clomipramine, desipramine, dosulepin (dothiepin), doxepin, imipramine, iprindole, lofepramine, nortriptyline, protriptyline, trimipramine)
- Typical antipsychotics (e.g., chlorpromazine, flupenthixol, fluphenazine, loxapine, perphenazine, prochlorperazine, thioridazine, thiothixene)
- Unknown/unsorted: Belarizine
- Elbanizine
- Flotrenizine
- Napactadine
- Tagorizine
- Trelnarizine
- Trenizine
|
|
H2 |
- Agonists: Amthamine
- Betazole
- Dimaprit
- Histamine
- HTMT
- Impromidine
- UR-AK49
- Antagonists: Bisfentidine
- Burimamide
- Cimetidine
- Dalcotidine
- Donetidine
- Ebrotidine
- Etintidine
- Famotidine
- Lafutidine
- Lamtidine
- Lavoltidine (loxtidine)
- Lupitidine
- Metiamide
- Mifentidine
- Niperotidine
- Nizatidine
- Osutidine
- Oxmetidine
- Pibutidine
- Quisultazine (quisultidine)
- Ramixotidine
- Ranitidine
- Roxatidine
- Sufotidine
- Tiotidine
- Tuvatidine
- Venritidine
- Xaltidine
|
|
H3 |
- Agonists: α-Methylhistamine
- Cipralisant
- Histamine
- Imetit
- Immepip
- Immethridine
- Methimepip
- Proxyfan
- Antagonists: A-349,821
- A-423,579
- ABT-239
- ABT-652
- AZD5213
- Betahistine
- Burimamide
- Ciproxifan
- Clobenpropit
- Conessine
- GSK-189,254
- Impentamine
- Iodophenpropit
- Irdabisant
- JNJ-5207852
- MK-0249
- NNC 38-1049
- PF-03654746
- Pitolisant
- SCH-79687
- Thioperamide
- VUF-5681
|
|
H4 |
- Agonists: 4-Methylhistamine
- α-Methylhistamine
- Histamine
- VUF-8430
- Antagonists: JNJ-7777120
- JNJ-38518168
- Mianserin
- Thioperamide
- VUF-6002
|
|
|
Transporter
(inhibitors) |
VMATs |
TAAR1 inactive |
- Amiodarone
- APP
- AZIK
- Bietaserpine
- Deserpidine
- Dihydrotetrabenazine
- Efavirenz
- GBR-12935
- GZ-793A
- Ibogaine
- Ketanserin
- Lobeline
- Methoxytetrabenazine
- NBI-98854
- Reserpine
- Rose bengal
- SD-809
- Tetrabenazine
- Vanoxerine (GBR-12909)
|
|
TAAR1 active |
- Amphetamine
- Methamphetamine
- MDMA
- Phenethylamine
|
|
|
|
Enzyme
(inhibitors) |
HDC |
- Catechin
- Meciadanol
- Naringenin
- Tritoqualine
|
|
HNMT |
- Amodiaquine
- Diphenhydramine
- Harmaline
- Metoprine
- Quinacrine
- SKF-91,488
- Tacrine
|
|
DAO |
|
|
|
Others |
|
|
Index of the respiratory system
|
|
Description |
- Anatomy
- Physiology
- Development
|
|
Disease |
- Congenital
- Neoplasms and cancer
- Chest trauma
- Infection
- common cold
- pneumonia
- tuberculosis
- Other
- Symptoms and signs
|
|
Treatment |
- Procedures
- Drugs
- nasal
- throat
- obstructive airway diseases
- cough and cold
- histaminergics
- pulmonary arterial hypertension
- other
- Surgery
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Simultaneous optimization of pH and binary organic composition by grid form modeling of the retention behavior in reversed-phase ultra high-performance liquid chromatography.
- Sasaki T1, Todoroki K2, Toyo'oka T3.
- Journal of pharmaceutical and biomedical analysis.J Pharm Biomed Anal.2017 Nov 30;146:251-260. doi: 10.1016/j.jpba.2017.08.047. Epub 2017 Sep 1.
- PMID 28888712
- Hyperosmolarity evokes histamine release from ileum mucosa by stimulating a cholinergic pathway.
- Wang B1, An N2, Shaikh AS3, Wang H1, Xiao L1, Liu H1, Li J1, Zhao D4.
- Biochemical and biophysical research communications.Biochem Biophys Res Commun.2017 Nov 18;493(2):1037-1042. doi: 10.1016/j.bbrc.2017.09.093. Epub 2017 Sep 19.
- PMID 28939039
- Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitis.
- Procopiou PA1, Ford AJ2, Gore PM3, Hancock AP3, Hodgson ST3, Holmes DS3, Looker BE3, Vile S3, Clark KL2, Saunders KA2, Slack RJ2, Watts CJ4.
- Bioorganic & medicinal chemistry letters.Bioorg Med Chem Lett.2017 Nov 1;27(21):4914-4919. doi: 10.1016/j.bmcl.2017.09.020. Epub 2017 Sep 9.
- PMID 28958623
Japanese Journal
- Histidine augments the suppression of hepatic glucose production by central insulin action.
- Kimura Kumi,Nakamura Yusuke,Inaba Yuka,Matsumoto Michihiro,Kido Yoshiaki,Asahara Shun-ichiro,Matsuda Tomokazu,Watanabe Hiroshi,Maeda Akifumi,Inagaki Fuyuhiko,Mukai Chisato,Takeda Kiyoshi,Akira Shizuo,Ota Tsuguhito,Nakabayashi Hajime,Kaneko Shuichi,Kasuga Masato,Inoue Hiroshi
- Diabetes 62(7), 2266-2277, 2013-07-00
- … Inhibition of HGP by histidine was also blocked by ICV administration of a histamine H1 receptor antagonist. … Therefore, histidine activates hepatic STAT3 and suppresses HGP via central histamine action. …
- NAID 120005334015
- Effect of Azelastine on Cardiac Repolarization of Guinea-Pig Cardiomyocytes, hERG K+ Channel, and Human L-type and T-type Ca2+ Channel
- Park Mi-Hyeong,Ho Lee Seung,Hyun Chu Dae,Hee Won Kwang,Hee Choi Bok,Choe Han,Jo Su-Hyun
- Journal of Pharmacological Sciences, 2013
- … Azelastine is a second generation histamine H1–receptor antagonist used as an anti-asthmatic and anti-allergic drug that can induce QT prolongation and torsades de pointes. …
- NAID 130003362736
- Combination of Leukotoriene Receptor Antagonist With Antihistamine Has an Additive Suppressive Effect on the Up-regulation of H1-Receptor mRNA in the Nasal Mucosa of Toluene 2,4-Diisocyanate-Sensitized Rat
- Kuroda Wakana,Kitamura Yoshiaki,Mizuguchi Hiroyuki,Miyamoto Yuko,Kalubi Bukasa,Fukui Hiroyuki,Takeda Noriaki
- Journal of Pharmacological Sciences, 2013
- … An attempt was made to clarify the additive suppressive effects of pranlukast, a cysteinyl leukotriene–receptor (LTR) antagonist, in combination with chlorpheniramine, an antihistamine, on the up-regulation of histamine H1–receptor (H1R) mRNA in toluene 2,4-diisocyanate (TDI)-sensitized rats. …
- NAID 130003362697
★リンクテーブル★
[★]
- 英
- H1 receptor
- 同
- ヒスタミンH1受容体 ヒスタミンH1レセプター histamine H1 receptor
- 関
- [[]]
- アレルギー反応に関与するヒスタミン受容体サブタイプ
[★]
- 英
- histamine H1 receptor
- 関
- H1受容体、ヒスタミンH1レセプター
[★]
- ヒスタミンH1受容体遮断薬、ヒスタミンH1受容体拮抗薬
- 関
- antihistamine、H1 blocker、histamine H1 antagonist
[★]
- 関
- H, H0, HX
- 胃癌の病期分類に用いられている。
- 肝転移の有無を示す。
- 肝転移を認める。
[★]